Renlong Zou
Ministry of Education(KR)China Medical University(CN)
Publications by Year
Research Areas
Ubiquitin and proteasome pathways, Prostate Cancer Treatment and Research, Epigenetics and DNA Methylation, Cancer, Lipids, and Metabolism, Genomics and Chromatin Dynamics
Most-Cited Works
- → Proteasome inhibitor MG132 induces BAG3 expression through activation of heat shock factor 1(2008)64 cited
- → RNF8 identified as a co-activator of estrogen receptor α promotes cell growth in breast cancer(2017)62 cited
- → MDC1 functionally identified as an androgen receptor co-activator participates in suppression of prostate cancer(2015)52 cited
- → USP22 positively modulates ERα action via its deubiquitinase activity in breast cancer(2020)42 cited
- → BAP18 coactivates androgen receptor action and promotes prostate cancer progression(2016)38 cited
- → MDC1 Enhances Estrogen Receptor-mediated Transactivation and Contributes to Breast Cancer Suppression(2015)37 cited
- → ASH2L is involved in promotion of endometrial cancer progression via upregulation of PAX2 transcription(2020)25 cited
- → MOF upregulates the estrogen receptor α signaling pathway by its acetylase activity in hepatocellular carcinoma(2021)22 cited
- → USP22 upregulates ZEB1-mediated VEGFA transcription in hepatocellular carcinoma(2023)21 cited
- → BAP18 is involved in upregulation of CCND1/2 transcription to promote cell growth in oral squamous cell carcinoma(2020)19 cited